A Study to Evaluate the Efficacy and Safety of Celecoxib Suspension Compared to Naproxen Suspension in Patients With JRA

NCT00652925 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

225

Enrollment

INDUSTRY

Sponsor class

Conditions

Arthritis, Juvenile Rheumatoid

Interventions

DRUG: Celecoxib
DRUG: Celecoxib
DRUG: Naproxen

Sponsor

Pfizer